Myelo Therapeutics' Series B Round

Myelo Therapeutics raised a round of funding on December 15, 2015.

Myelo Therapeutics is a pharmaceutical company that develops innovative treatments in areas with high unmet medical needs. Its lead compound, Myelo001, is a small molecule for the treatment of patient…

Articles about Myelo Therapeutics' Series B Round: